Inhibition of glucocorticoid synthesis alleviates cognitive impairment in high-fat diet-induced obese mice
Ontology highlight
ABSTRACT: In addition to cardiovascular diseases, metabolic syndrome and type 2 diabetes mellitus, obesity is associated with cognitive deficits. In rodents, it has been shown that long-term high-fat diet (HFD) consumption leads to the alteration of hypothalamic-pituitary-adrenal (HPA) axis resulting in increased corticosterone release. However, mechanisms underpinning cognitive impairments induced by long-term HFD intake are unclear. Herein we evaluated the effects of systemic administration of glucocorticoid synthesis inhibitor metyrapone on cognitive performance assessed by novel object recognition test and plasma corticosterone levels evaluated by enzyme-linked immunosorbent assay in HFD-induced obese mice. We found that metyrapone treatment alleviated recognition memory impairments in HFD-induced obese mice. Furthermore, glucocorticoid synthesis inhibitor also lowered plasma corticosterone levels in HFD-induced obese mice. Our findings indicate that hyperactivation of HPA axis resulting in elevated circulating glucocorticoid levels leads to memory impairments in HFD-induced obese mice. We identify glucocorticoid system as a potential therapeutic target for treating cognitive deficits associated with obesity condition. Highlights • High-fat diet-induced obesity impaired recognition memory in mice.• High-fat diet-induced obesity increased circulating corticosterone levels in mice.• Glucocorticoid synthesis inhibitor administration alleviated recognition memory deficits in high-fat diet-induced obese mice.• Glucocorticoid synthesis inhibitor administration lowered circulating corticosterone levels in high-fat diet-induced obese mice.
SUBMITTER: Janthakhin Y
PROVIDER: S-EPMC9216272 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA